“Heart care providers have always valued minimally invasive procedures for their patients,” Corcym CEO Christian Mazzi said. “Now we’re bringing those benefits to surgery itself, without compromising the long-term outcomes that define it.”
In the procedure, Dr. Michael Ibrahim replaced a patient’s aortic valve with the robotic delivery system in a procedure performed with Intuitive’s da Vinci 5 robotic surgical system. The patient returned home three days post-procedure, Corcym said.
“The development of the RelyON-R robotic delivery system reflects a shift toward purpose-designed tools that will unlock the full potential of robotic cardiac surgery,” Ibrahim said.
Corcym said the delivery system would enable the benefits of a surgical robot’s precision, visualization and positioning and support more consistent valve delivery and deployment in robotic-assisted settings.
Last year, Corcym’s sutureless valve was used in a robotic aortic valve replacement through a small incision in the patient’s neck. The replacement was performed with CardioPrecision’s CoreVista Robot Enabling platform in a AVATAR procedure, or Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot assistance.
RelyOn-R is designed to be fully compatible with CoreVista and facilitate the robotic transcervical approach.
As of publication, the delivery system is not FDA approved and not commercially available. Corcym said this first human procedure represents early investigational use and a milestone in its broader development efforts to advance techniques that combine the durability of surgery with the reduced physical impact of robotic approaches.
